Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernat Crosas

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Cell|December 28, 2006
Ubiquitin chains are remodeled at the proteasome by opposing ubiquitin ligase and deubiquitinating activitiesBernat Crosas, John Hanna, Donald S Kirkpatrick, et al.
Nature Communications|March 28, 2026
Expanding the targeted protein degradation approach with small molecule chimeras directed to the 26S proteasomeMireia Casasampere, Hector Carneros, Tania Roda, et al.
Journal of Medical Virology|February 4, 2025
Induction of the Inflammasome by the SARS-CoV-2 Accessory Protein ORF9b, Abrogated by Small-Molecule ORF9b Homodimerization InhibitorsErika Zodda, Mònica Pons, Natàlia DeMoya-Valenzuela, et al.
Plos One|July 9, 2010
Protein-protein interaction antagonists as novel inhibitors of non-canonical polyubiquitylationJohanna Scheper, Marta Guerra-Rebollo, Glòria Sanclimens, et al.
Cell Death Discovery|April 8, 2026
Proteasome dysfunction underlies HERC2-linked neurodevelopmental disorder with Angelman-like clinical featuresJoan Sala-Gaston, Laura Costa-Sastre, Manel Garcia-Diez, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cell|December 28, 2006
Ubiquitin chains are remodeled at the proteasome by opposing ubiquitin ligase and deubiquitinating activitiesBernat Crosas, John Hanna, Donald S Kirkpatrick, et al.
Nature Communications|March 28, 2026
Expanding the targeted protein degradation approach with small molecule chimeras directed to the 26S proteasomeMireia Casasampere, Hector Carneros, Tania Roda, et al.
Journal of Medical Virology|February 4, 2025
Induction of the Inflammasome by the SARS-CoV-2 Accessory Protein ORF9b, Abrogated by Small-Molecule ORF9b Homodimerization InhibitorsErika Zodda, Mònica Pons, Natàlia DeMoya-Valenzuela, et al.
Plos One|July 9, 2010
Protein-protein interaction antagonists as novel inhibitors of non-canonical polyubiquitylationJohanna Scheper, Marta Guerra-Rebollo, Glòria Sanclimens, et al.
Cell Death Discovery|April 8, 2026
Proteasome dysfunction underlies HERC2-linked neurodevelopmental disorder with Angelman-like clinical featuresJoan Sala-Gaston, Laura Costa-Sastre, Manel Garcia-Diez, et al.
Pageof 3